Heightened expression of survivin in activated T lymphocytes from patients with multiple sclerosis
- 1 October 2001
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 119 (2) , 358-364
- https://doi.org/10.1016/s0165-5728(01)00389-7
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- BIRinging Chromosomes through Cell Division—And Survivin' the ExperienceCell, 2000
- Smac, a Mitochondrial Protein that Promotes Cytochrome c–Dependent Caspase Activation by Eliminating IAP InhibitionCell, 2000
- Ubiquitin Protein Ligase Activity of IAPs and Their Degradation in Proteasomes in Response to Apoptotic StimuliScience, 2000
- Control of Apoptosis during Angiogenesis by Survivin Expression in Endothelial CellsThe American Journal of Pathology, 2000
- Immune (dys)regulation in multiple sclerosis: role of the CD95–CD95 ligand systemImmunology Today, 1999
- Expression of the Novel Inhibitor of Apoptosis Survivin in Normal and Neoplastic SkinJournal of Investigative Dermatology, 1999
- Serum Levels of Apoptosis-Related Molecules in Patients with Multiple Sclerosis and Human T-Lymphotropic Virus Type I-Associated MyelopathyJournal of Interferon & Cytokine Research, 1999
- Activation‐induced apoptosis of autoreactive and alloreactive T lymphocytes in the target organ as a major mechanism of toleranceImmunology & Cell Biology, 1999
- Fas/APO-1/CD95 in health and autoimmune disease: thymic and peripheral aspectsSeminars in Immunology, 1998
- Serum sAPO-1/Fas levels in multiple sclerosisActa Neurologica Scandinavica, 1997